• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性卒中患者的基线血压与计算机断层扫描结果之间的关系:来自急性缺血性卒中替奈普酶试验(TAIST)的数据。

The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).

作者信息

Sare Gillian M, Bath Philip M W, Gray Laura J, Moulin Thierry, Woimant France, England Timothy, Geeganage Chamila, Christensen Hanne, De Deyn Peter Paul, Leys Didier, O'Neill Desmond, Ringelstein E Bernd

机构信息

Stroke Trials Unit, University of Nottingham, Clinical Sciences Building, City Hospital campus, Nottingham NG7 2UH UK.

出版信息

Stroke. 2009 Jan;40(1):41-6. doi: 10.1161/STROKEAHA.108.526665. Epub 2008 Nov 6.

DOI:10.1161/STROKEAHA.108.526665
PMID:18988907
Abstract

BACKGROUND AND PURPOSE

High blood pressure (BP) is present in approximately 80% of patients with acute ischemic stroke and is independently associated with poor outcome. There are few data examining the relationship between admission BP and acute CT findings.

METHODS

TAIST was a randomized controlled trial assessing 10 days of treatment with tinzaparin versus aspirin in 1489 patients with acute ischemic stroke (<48 hr) with admission BP of </=220/120 mmHg. CT brain scans were performed before randomization and after 10 days. The relationships between baseline BP and adjudicated CT findings were assessed. Odds ratios per 10 mmHg change in BP were calculated.

RESULTS

Higher systolic BP (SBP) was associated with abnormal CT scans because of independent associations with chronic changes of leukoariosis (OR, 1.12; 95% CI, 1.05-1.17) and old infarction (OR, 1.12; 95% CI, 1.06-1.17) at baseline, and signs of visible infarction at day 10 (OR, 1.06; 95% CI, 1.00-1.13). A lower SBP was associated with signs of acute infarction (OR, 0.94; 95% CI, 0.89-0.99). Hemorrhagic transformation, dense middle cerebral artery sign, mass effect, and cerebral edema at day 10 were not independently associated with baseline BP.

CONCLUSIONS

Although high baseline BP is independently associated with a poor outcome after stroke, this was not shown to be through an association with increased hemorrhagic transformation, cerebral edema, or mass effect; trial design may be suboptimal to detect this. Higher SBP is associated with visible infarction on day 10 scans. The influence of changing BP in acute stroke on CT findings is still to be ascertained.

摘要

背景与目的

约80%的急性缺血性卒中患者存在高血压,且高血压与不良预后独立相关。关于入院血压与急性CT表现之间关系的数据较少。

方法

TAIST是一项随机对照试验,在1489例急性缺血性卒中(<48小时)且入院血压≤220/120 mmHg的患者中,评估替奈肝素与阿司匹林治疗10天的效果。在随机分组前和10天后进行头颅CT扫描。评估基线血压与判定的CT表现之间的关系。计算血压每变化10 mmHg的比值比。

结果

较高的收缩压(SBP)与CT扫描异常相关,这是因为在基线时SBP与白质疏松症的慢性改变(比值比,1.12;95%可信区间,1.05 - 1.17)和陈旧性梗死(比值比,1.12;95%可信区间,1.06 - 1.17)独立相关,且与第10天可见梗死的征象相关(比值比,1.06;95%可信区间,1.00 - 1.13)。较低的SBP与急性梗死的征象相关(比值比,0.94;95%可信区间,0.89 - 0.99)。第10天的出血转化、大脑中动脉高密度征、占位效应和脑水肿与基线血压无独立相关性。

结论

尽管高基线血压与卒中后不良预后独立相关,但这并非通过与出血转化增加、脑水肿或占位效应相关来体现;试验设计可能不足以检测到这一点。较高的SBP与第10天扫描时可见的梗死相关。急性卒中时血压变化对CT表现的影响仍有待确定。

相似文献

1
The relationship between baseline blood pressure and computed tomography findings in acute stroke: data from the tinzaparin in acute ischaemic stroke trial (TAIST).急性卒中患者的基线血压与计算机断层扫描结果之间的关系:来自急性缺血性卒中替奈普酶试验(TAIST)的数据。
Stroke. 2009 Jan;40(1):41-6. doi: 10.1161/STROKEAHA.108.526665. Epub 2008 Nov 6.
2
Asymptomatic hemorrhagic transformation of infarction and its relationship with functional outcome and stroke subtype: assessment from the Tinzaparin in Acute Ischaemic Stroke Trial.无症状性梗死出血转化及其与功能结局和卒中亚型的关系:来自替奈普酶治疗急性缺血性卒中试验的评估。
Stroke. 2010 Dec;41(12):2834-9. doi: 10.1161/STROKEAHA.109.573063. Epub 2010 Oct 28.
3
Stroke severity, early recovery and outcome are each related with clinical classification of stroke: data from the 'Tinzaparin in Acute Ischaemic Stroke Trial' (TAIST).中风严重程度、早期恢复情况和预后均与中风的临床分类相关:来自“替奈普酶治疗急性缺血性中风试验”(TAIST)的数据。
J Neurol Sci. 2007 Mar 15;254(1-2):54-9. doi: 10.1016/j.jns.2006.12.016. Epub 2007 Jan 29.
4
Relationship between outcome and baseline blood pressure and other haemodynamic measures in acute ischaemic stroke: data from the TAIST trial.急性缺血性卒中结局与基线血压及其他血流动力学指标的关系:来自TAIST试验的数据。
J Hypertens. 2006 Jul;24(7):1413-7. doi: 10.1097/01.hjh.0000234123.55895.12.
5
Sex differences in quality of life in stroke survivors: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).中风幸存者生活质量的性别差异:来自急性缺血性中风试验(TAIST)中替扎肝素的数据。
Stroke. 2007 Nov;38(11):2960-4. doi: 10.1161/STROKEAHA.107.488304. Epub 2007 Sep 27.
6
Relationship between baseline blood pressure parameters (including mean pressure, pulse pressure, and variability) and early outcome after stroke: data from the Tinzaparin in Acute Ischaemic Stroke Trial (TAIST).基线血压参数(包括平均压、脉压和变异性)与卒中后早期结局的关系:来自替奈普酶治疗急性缺血性卒中试验(TAIST)的数据。
Stroke. 2011 Feb;42(2):491-3. doi: 10.1161/STROKEAHA.110.596163. Epub 2010 Dec 23.
7
Association of characteristics of blood pressure profiles and stroke outcomes in the ECASS-II trial.欧洲急性卒中协作研究II期试验中血压曲线特征与卒中结局的关联
Stroke. 2008 Feb;39(2):366-72. doi: 10.1161/STROKEAHA.107.492330. Epub 2007 Dec 20.
8
Factors influencing acute blood pressure values in stroke subtypes.影响卒中亚型急性血压值的因素。
J Hum Hypertens. 2004 Apr;18(4):253-9. doi: 10.1038/sj.jhh.1001662.
9
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.急性卒中溶栓治疗后,体内铁储备增加与预后不良相关。
Stroke. 2007 Jan;38(1):90-5. doi: 10.1161/01.STR.0000251798.25803.e0. Epub 2006 Nov 30.
10
Long-term outcome as function of blood pressure in acute ischemic stroke and effects of thrombolysis.急性缺血性卒中患者长期预后与血压的关系及溶栓治疗的影响
Cerebrovasc Dis. 2007;24(4):349-54. doi: 10.1159/000106981. Epub 2007 Aug 9.

引用本文的文献

1
Antihypertensive therapy in acute ischemic stroke: where do we stand?急性缺血性脑卒中的降压治疗:我们处于什么位置?
J Hum Hypertens. 2018 Dec;32(12):799-807. doi: 10.1038/s41371-018-0105-7. Epub 2018 Sep 19.